Since increased BMI (or obesity) is unlikely to affect the binding of posaconazole to albumin [17], the free fraction is expected to remain unaffected, and thus, a decrease in total concentration will subsequently result in a lower unbound concentration. This evidence concerns the gene ALB and obesity due to melanocortin 4 receptor deficiency.